Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer

Radiotherapy and Oncology

Volumn 100, Issue 1, 2011, Pages 116-123

  Pötter, Richard ^a   Georg, Petra ^a   Dimopoulos, Johannes C A ^b   Grimm, Magdalena ^a   Berger, Daniel ^a   Nesvacil, Nicole ^a   Georg, Dietmar ^a   Schmid, Maximilian P ^a   Reinthaller, Alexander ^a   Sturdza, Alina ^a   Kirisits, Christian ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b METROPOLITAN HOSPITAL   (Greece)

Author keywords

Cervical cancer; Clinical outcome; GEC ESTRO recommendations; Image guided adaptive brachytherapy

Indexed keywords

CISPLATIN;

ADULT; ADVANCED CANCER; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED RADIOTHERAPY; DEFECATION URGENCY; DIARRHEA; DOSIMETRY; DYSPAREUNIA; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; RECTOVAGINAL FISTULA; RECTUM HEMORRHAGE; RECTUM PERFORATION; RECTUM ULCER; TELANGIECTASIA; TREATMENT OUTCOME; TUMOR VOLUME; URINARY FREQUENCY; URINARY URGENCY; UTERINE CERVIX CARCINOMA; VAGINA DISEASE; VAGINA OBLITERATION;

BRACHYTHERAPY; CHEMORADIOTHERAPY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 80051789536     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.07.012     Document Type: Article

References (70)

1. S.M. Bentzen Radiation oncology health technology assessment: the best is the enemy of the good Nat Clin Pract Oncol 5 2008 563
2. D.I. Thwaites, and D. Verellen Vorsprung durch Technik: evolution, implementation, QA and safety of new technology in radiotherapy Radiother Oncol 94 2010 125 128
3. D. Verellen, M. De Ridder, N. Linthout, K. Tournel, G. Soete, and G. Storme Innovations in image-guided radiotherapy Nat Rev Cancer 7 2007 949 960 (Pubitemid 350165868)
4. T. Bortfeld, R. Schmidt-Ullrich, W. DeNeve, and D. Wazer Image-Guided IMRT 2005 Springer
5. S. Webb Contemporary IMRT: Developing Physics and Clinical Implementation 2004 Institute of Physics Publishing Bristol
6. C. Haie-Meder, R. Pötter, and E. Van Limbergen Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV Radiother Oncol 74 2005 235 245 (Pubitemid 40349132)
7. R. Potter, C. Haie-Meder, and E. Van Limbergen Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology Radiother Oncol 78 2006 67 77 (Pubitemid 43131038)
8. J.C. Dimopoulos, G. Schard, and D. Berger Systematic evaluation of MRI findings in different stages of treatment of cervical cancer: potential of MRI on delineation of target, pathoanatomic structures, and organs at risk Int J Radiat Oncol Biol Phys 64 2006 1380 1388
9. A.N. Viswanathan, J. Dimopoulos, C. Kirisits, D. Berger, and R. Pötter Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: results of a prospective trial and preliminary guidelines for standardized contours Int J Radiat Oncol Biol Phys 68 2007 491 498 (Pubitemid 46694166)
10. C. Kirisits, R. Pötter, S. Lang, J. Dimopoulos, N. Wachter-Gerstner, and D. Georg Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer Int J Radiat Oncol Biol Phys 62 2005 901 911 (Pubitemid 40779785)
11. J.C. Dimopoulos, C. Kirisits, and P. Petric The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: clinical feasibility and preliminary results Int J Radiat Oncol Biol Phys 66 2006 83 90 (Pubitemid 44175668)
12. I.M. Jurgenliemk-Schulz, R.J. Tersteeg, and J.M. Roesink MRI-guided treatment-planning optimisation in intracavitary or combined intracavitary/interstitial PDR brachytherapy using tandem ovoid applicators in locally advanced cervical cancer Radiother Oncol 93 2009 322 330
13. R. Pötter, J. Dimopoulos, and P. Georg Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer Radiother Oncol 83 2007 148 155 (Pubitemid 46783926)
14. H.M. Keys, B.N. Bundy, and F.B. Stehman Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma N Engl J Med 340 1999 1154 1161 (Pubitemid 29177874)
15. M. Morris, P.J. Eifel, and J. Lu Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer N Engl J Med 340 1999 1137 1143 (Pubitemid 29177872)
16. W.A. Peters 3rd, Liu, PY, Barrett, RJ, 2nd, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix J Clin Oncol 18 2000 1606 1613
17. P.G. Rose, B.N. Bundy, and E.B. Watkins Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer N Engl J Med 340 1999 1144 1153 (Pubitemid 29177873)
18. C.W. Whitney, W. Sause, and B.N. Bundy Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study J Clin Oncol 17 1999 1339 1348 (Pubitemid 29220838)
19. C. Vale, J.F. Thierny, and L.A. Stewart Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials J Clin Oncol 26 2008 5802 5812
20. S. Michiels, A. Le Maitre, and M. Buyse Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data Lancet Oncol 10 2009 341 350
21. A. Duenas-Gonzalez, J.J. Zarba, and F. Patel Phase III, Open-Label, Randomized Study Comparing Concurrent Gemcitabine Plus Cisplatin and Radiation Followed by Adjuvant Gemcitabine and Cisplatin Versus Concurrent Cisplatin and Radiation in Patients With Stage IIB to IVA Carcinoma of the Cervix J Clin Oncol 29 2011 1678 1685
22. M.A. Quinn, J.L. Benedet, and F. Odicino Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer Int J Gynaecol Obstet 95 2006 S43 103
23. Hunter, RD, Davidson, SE. Low dose-rate brachytherapy for treating cervix cancer: changing dose rate. In: Joslin CAF FA, Hall E, editor. Principles and practice of brachytherapy using afterloading systems, London: Arnold. 2001;343-353.
24. W.J. Meredith Radium Dosage: The Manchester System 1967 Livingstone Edinburgh
25. C.A. Perez, P.W. Grigsby, K.S. Chao, D.G. Mutch, and M.A. Lockett Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix Int J Radiat Oncol Biol Phys 41 1998 307 317 (Pubitemid 28243542)
26. G.H. Fletcher, and A.D. Hamburger Female Pelvis. Squamos cell carcinoma of the Uterine Cervix G.H. Fletcher, Textbook of Radiotherapy 1980 Lea and Febiger Philadelphia 720 789 third edition
27. C.A. Perez, S. Breaux, and J.M. Bedwinek Radiation therapy alone in the treatment of carcinoma of the uterine cervix. II. Analysis of complications Cancer 54 1984 235 246 (Pubitemid 14076604)
28. P.J. Eifel, J. Moughan, J. Owen, A. Katz, I. Mahon, and G.E. Hanks Patterns of radiotherapy practice for patients with squamous carcinoma of the uterine cervix: patterns of care study Int J Radiat Oncol Biol Phys 43 1999 351 358 (Pubitemid 29091476)
29. A. Gerbaulet, G. Michel, and C. Haie-Meder The role of low dose rate brachytherapy in the treatment of cervix carcinoma. Experience of the Gustave-Roussy Institute on 1245 patients Eur J Gynaecol Oncol 16 1995 461 475
30. C. Haie-Meder, C. Chargari, A. Rey, I. Dumas, P. Morice, and N. Magne DVH parameters and outcome for patients with early-stage cervical cancer treated with preoperative MRI-based low dose rate brachytherapy followed by surgery Radiother Oncol 93 2009 316 321
31. L.T. Tan, C.E. Coles, C. Hart, and E. Tait Clinical impact of computed tomography-based image-guided brachytherapy for cervix cancer using the tandem-ring applicator - the Addenbrooke's experience Clin Oncol (R Coll Radiol) 21 2009 175 182
32. K. Narayan, S. van Dyk, D. Bernshaw, C. Rajasooriyar, and S. Kondalsamy-Chennakesavan Comparative study of LDR (Manchester system) and HDR image-guided conformal brachytherapy of cervical cancer: patterns of failure, late complications, and survival Int J Radiat Oncol Biol Phys 74 2009 1529 1535
33. H.C. Kang, K.H. Shin, S.Y. Park, and J.Y. Kim 3D CT-based high-dose-rate brachytherapy for cervical cancer: clinical impact on late rectal bleeding and local control Radiother Oncol 97 2010 507 513
34. C. Wittekind, and H-J. HMeyer UICC: TNM Klassifikation maligner Tumoren 2002 Springer Berlin Heidelberg New York
35. C. Kirisits, S. Lang, J. Dimopoulos, D. Berger, D. Georg, and R. Pötter The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: design, application, treatment planning, and dosimetric results Int J Radiat Oncol Biol Phys 65 2006 624 630
36. J.C. Dimopoulos, R. Pötter, and S. Lang Dose-effect relationship for local control of cervical cancer by magnetic resonance image-guided brachytherapy Radiother Oncol 93 2009 311 315
37. J.C. Dimopoulos, S. Lang, and C. Kirisits Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy Int J Radiat Oncol Biol Phys 75 2009 56 63
38. S. Lang, C. Kirisits, J. Dimopoulos, D. Georg, and R. Pötter Treatment planning for MRI assisted brachytherapy of gynecologic malignancies based on total dose constraints Int J Radiat Oncol Biol Phys 69 2007 619 627 (Pubitemid 47380110)
39. P. Georg, S. Lang, and J.C. Dimopoulos Dose-volume histogram parameters and late side effects in magnetic resonance image-guided adaptive cervical cancer brachytherapy Int J Radiat Oncol Biol Phys 79 2011 356 362
40. Georg, P, Potter, R, Georg, D, et al. Dose Effect Relationship for Late Side Effects of the Rectum and Urinary Bladder in Magnetic Resonance Image-Guided Adaptive Cervix Cancer Brachytherapy. Int J Radiat Oncol Biol Phys, in press, doi:10.1016/j.ijrobp.2010.12.029.
41. C. Chargari, N. Magne, and I. Dumas Physics Contributions and Clinical Outcome with 3D-MRI-Based Pulsed-Dose-Rate Intracavitary Brachytherapy in Cervical Cancer Patients Int J Radiat Oncol Biol Phys 74 2009 185 193
42. U. Mahantshetty, S. Banerjee, S. Chopra, R. Engineer, and S.K. Shrivastava Clincal outcome of patients treated with template based high dose rate (HDR) interstitial brachytherapy boost in gynecological malignancies Radiother Oncol 99 2011 S117
43. S. Beriwal, A. Bhatnagar, and D.E. Heron High-dose-rate interstitial brachytherapy for gynecologic malignancies Brachytherapy 5 2006 218 222 (Pubitemid 44752117)
44. C. Charra-Brunaud, M. Levitchi, and M. Delannes Dosimetric, clinical results of a French prospective study of 3D brachytherapy for cervix carcinoma Radiother Oncol 99 2011 S57
45. R. Pötter, T.H. Knocke, C. Fellner, M. Baldass, A. Reinthaller, and H. Kucera Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations Cancer Radiother 4 2000 159 172 (Pubitemid 30238928)
46. R. Pötter, J. Dimopoulos, and B. Bachtiary 3D conformal HDR-brachy- and external beam therapy plus simultaneous cisplatin for high-risk cervical cancer: clinical experience with 3 year follow-up Radiother Oncol 79 2006 80 86
47. C.B. Lee, T.E. Stinchcombe, J.G. Rosenman, and M.A. Socinski Therapeutic advances in local-regional therapy for stage III non-small-cell lung cancer: evolving role of dose-escalated conformal (3-dimensional) radiation therapy Clin Lung Cancer 8 2006 195 202 (Pubitemid 44896392)
48. F. Duprez, K. Bonte, W. De Neve, T. Boterberg, W. De Gersem, and I. Madani Regional relapse after intensity-modulated radiotherapy for head-and-neck cancer Int J Radiat Oncol Biol Phys 79 2011 450 458
49. I. Deutsch, M.J. Zelefsky, and Z. Zhang Comparison of PSA relapse-free survival in patients treated with ultra-high-dose IMRT versus combination HDR brachytherapy and IMRT Brachytherapy 9 2010 313 318
50. S. Lang, A. Nulens, and E. Briot Intercomparison of treatment concepts for MR image assisted brachytherapy of cervical carcinoma based on GYN GEC-ESTRO recommendations Radiother Oncol 78 2006 185 193 (Pubitemid 43344179)
51. I.M. Jurgenliemk-Schulz, S. Lang, and K. Tanderup Variation of treatment planning parameters (D90 HR-CTV, D 2cc for OAR) for cervical cancer tandem ring brachytherapy in a multicentre setting: comparison of standard planning and 3D image guided optimisation based on a joint protocol for dose-volume constraints Radiother Oncol 94 2009 339 345
52. M. De Brabandere, A.G. Mousa, A. Nulens, A. Swinnen, and E. Van Limbergen Potential of dose optimisation in MRI-based PDR brachytherapy of cervix carcinoma Radiother Oncol 88 2008 217 226
53. J.C. Lindegaard, K. Tanderup, S.K. Nielsen, S. Haack, and J. Gelineck MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer Int J Radiat Oncol Biol Phys 71 2008 756 764
54. R. Pötter, C. Kirisits, and E.F. Fidarova Present status and future of high-precision image guided adaptive brachytherapy for cervix carcinoma Acta Oncol 47 2008 1325 1336
55. K. Tanderup, J.C. Lindegaard, and C. Kirisits EMBRACE Radiother Oncol 99 2011 S22
56. A. Sturdza, J.C. Lindegaard, and L.U. Fokdal Retro-EMBRACE: Preliminary results of image guided BT for cervical cancer in the last years of the 20st century Radiother Oncol 99 2011 S22
57. J.C. Dimopoulos, V. De Vos, and D. Berger Inter-observer comparison of target delineation for MRI-assisted cervical cancer brachytherapy: application of the GYN GEC-ESTRO recommendations Radiother Oncol 91 2009 166 172
58. J.C. Dimopoulos, G. Schirl, A. Baldinger, T.H. Helbich, and R. Pötter MRI assessment of cervical cancer for adaptive radiotherapy Strahlenther Onkol 185 2009 282 287
59. T.P. Hellebust, C. Kirisits, and D. Berger Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group: considerations and pitfalls in commissioning and applicator reconstruction in 3D image-based treatment planning of cervix cancer brachytherapy Radiother Oncol 96 2010 153 160
60. P. Trnkova, R. Potter, and D. Baltas New inverse planning technology for image-guided cervical cancer brachytherapy: description and evaluation within a clinical frame Radiother Oncol 93 2009 331 340
61. I.M. Jurgenliemk-Schulz, S. Lang, and K. Tanderup Variation of treatment planning parameters (D90 HR-CTV, D 2cc for OAR) for cervical cancer tandem ring brachytherapy in a multicentre setting: comparison of standard planning and 3D image guided optimisation based on a joint protocol for dose-volume constraints Radiother Oncol 94 2010 339 345
62. K. Tanderup, R. Potter, J.C. Lindegaard, D. Berger, A. Wambersie, and C. Kirisits PTV margins should not be used to compensate for uncertainties in 3D image guided intracavitary brachytherapy Radiother Oncol 97 2010 495 500
63. A.N. Viswanathan The Frank Ellis memorial lecture: the use of three-dimensional imaging in gynaecological radiation therapy Clin Oncol (R Coll Radiol) 20 2008 1 5
64. L.J. Lee, C.A. Sadow, A. Russell, and A.N. Viswanathan Correlation of point B and lymph node dose in 3D-planned high-dose-rate cervical cancer brachytherapy Int J Radiat Oncol Biol Phys 75 2009 803 809
65. K. Tanderup, S. Nielsen, and G. Nyvang From point A to the sculpted pear: MR image guidance significantly improves tumour dose and sparing organs at risk in brachytherapy of cervical cancer Radiother Oncol 94 2010 173 180
66. W.S. Koom, D.K. Sohn, and J.Y. Kim Computed tomography-based high-dose-rate intracavitary brachytherapy for uterine cervical cancer: preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy Int J Radiat Oncol Biol Phys 68 2007 1446 1454 (Pubitemid 47176797)
67. E.F. Fidarova, D. Berger, and S. Schussler Dose volume parameter D2cc does not correlate with vaginal side effects in individual patients with cervical cancer treated within a defined treatment protocol with very high brachytherapy doses Radiother Oncol 97 2010 76 79
68. P. Georg, C. Kirisits, and G. Goldner Correlation of dose-volume parameters, endoscopic and clinical rectal side effects in cervix cancer patients treated with definitive radiotherapy including MRI-based brachytherapy Radiother Oncol 91 2009 173 180
69. Van de Kamer, JB, De Leeuw, AA, Moerland, MA, Jurgenliemk-Schulz, IM. Determining DVH parameters for combined external beam and brachytherapy treatment: 3D biological dose adding for patients with cervical cancer. Radiother Oncol 2010;94:248-253.
70. V. Lorvidhaya, I. Chitapanarux, and S. Sangruchi Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: a randomized trial Int J Radiat Oncol Biol Phys 55 2003 1226 1232 (Pubitemid 36338288)